Back to search
Muscular Ventricular Septal Defect
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Muscular Ventricular Septal Defect trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Muscular Ventricular Septal Defect trials you may qualify forThe Abbott Structural Heart (SH) Registry is being conducted to confirm the safety and performance of Abbott's SH devices in a post-market, real-world setting.…
The Occlutech® mVSD is indicated for percutaneous occlusion of hemodynamically or clinically significant muscular ventricular septal defects. The objectives of…
In 2019, the international study titled "CAUTION Study - 1" (MeChanical complicAtions of acUte myocardial infarcTion: an InternatiOnal multiceNter cohort study)…
A single-arm, non-randomized, multi-center clinical study of the Amplatzer™ Trevisio™ Intravascular Delivery System for facilitating percutaneous, transcatheter…
The AMPLATZER Muscular VSD Occluder was approved by the US Food and Drug Administration (FDA) in September, 2007. This study is designed to further evaluate the…